Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For Patients With Type 1 Diabetes
Aged 18-65
Presence of type 1 diabetes mellitus.
2-25 year duration.
For Patients With Type 2 Diabetes
Aged 25-65 years
presence of type 2 diabetes mellitus.
2 years since initial diagnosis.
You may not be if
Renal disease, microalbumin \>300 ug/mg)
Severe peripheral diabetic neuropathy and/or severe peripheral vascular disease
Symptomatic severe autonomic neuropathy who may be at risk when increasing activity levels.
Women who are currently pregnant
proliferative diabetic retinopathy based on dilated eye examination within one year of study entry. Patients whose eye disease is successfully treated will be included.
HbA1c levels less than 7.0% (normal range 4.0 - 6.0%).
HbA1c levels greater than 14.0%
patients who underwent intensive insulin treatment within one year
a history of severe, unstable myocardial infarction, congestive heart failure or other severe cardiac disease, severe hypertension (systolic more than 160 mmHg or diastolic 90 mmHg) who may be at risk when mildly increasing physical activity
a DSMIV diagnosis of eating disorders including anorexia nervosa, bulimia, and severe weight-related insulin omission.
Patients with recent diagnosis (past 6 months) of bipolar disorder, schizophrenia, mental retardation, organic mental disorder, and alcohol or drug abuse
Patients whose diabetes diagnosed cannot be clearly classified as type 1 or type 2.
Clareo Health | Breaking Down Barriers to Diabetes Self-Care
